PON1 antibody

Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
PON1 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab06638
tested applications
ELISA, WB, IHC, IP
Description
Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones, and a number of aromatic carboxylic acid esters. Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation.
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | paraoxonase 1 (PON1) |
Host | Rabbit |
Reactivity | Human, Mouse, Rat |
Recommended Dilution | WB: 1:200-1:2000; IP: 1:200-1:2000; IHC: 1:20-1:200 |
Clonality | polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Observed MW | 42-45 kDa |
Purity | ≥95% as determined by SDS-PAGE |
Purification | Immunogen affinity purified |
Size 1 | 100µg |
Form | liquid |
Tested Applications | ELISA, WB, IHC, IP |
Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
UniProt ID | P27169 |
Gene ID | 5444 |
Alias | Serum paraoxonase/arylesterase 1 (PON 1),Aromatic esterase 1 (A-esterase 1),K-45,Serum aryldialkylphosphatase 1,PON1,PON |
Background | Antibody anti-PON1 |
Status | RUO |
Note | Mol. Weight 42-45 kDa |
Descripción
Related Products

Human PON1 (Serum paraoxonase/arylesterase 1) ELISA Kit
Ver Producto
Rat Pon1 (Serum paraoxonase/arylesterase 1) ELISA Kit
Ver Producto
PON1 antibody
Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones, and a number of aromatic carboxylic acid esters. Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation.
Ver Producto